• Statins, Mucolytics May Lower Risk of Exacerbations, Death Among BCO Patients, Study Finds
  • Apulmiq’s Benefits Confirmed in Third-party Evaluation
  • Rising Healthcare Costs Strain EU Budgets Even as New Therapies Flourish
  • Mycobacterium abscessus Gave Rise to Autoimmune Disorder in Bronchiectasis Patient, Report Says
  • Zambon’s Inhalable Antibiotic for Non-CF Bronchiectasis Gets Fast Track, QIDP Status from FDA
  • ‘Vascular Pruning’ Affects Lung Function in Smokers With Bronchiectasis
  • Pus in Sputum Associated with Disease-prone Bacteria in Bronchiectasis
  • Certain Autoantibodies Linked to P. aeruginosa Infection in Bronchiectasis Patients, Study Suggests
  • New Probe Allows Safe, Easy Visualization of Infectious Bacteria in Lungs, Study Shows
  • B. bronchiseptica Infection Causes Varied Symptoms in Non-CF Bronchiectasis Patients, Case Series Shows
  • #NORDSummit – Major Issues on Table for Rare Disease Patients in US as Midterm Elections Approach
  • Benefits of Sinus Surgery in Bronchiectasis Patients Do Not Extend to Lung Function, Study Suggests